Back to search

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Carcinoma, Non-Small-Cell Lung
Clinicaltrials.gov:
EU CTIS:
#2023-505863-35-00
Other:
#61186372NSC2007
Subscribe or share this trial
Countries:
  • Argentina,
  • Brazil,
  • China,
  • France,
  • Germany,
  • Malaysia,
  • South Korea,
  • Spain,
  • Taiwan,
  • Turkey (Türkiye),
  • United States
Loading...
Adana, Turkey (Türkiye), 1060
Ankara, Turkey (Türkiye), 6800
Vitória, Brazil, 29043-260
Istanbul, Turkey (Türkiye), 34147
Belém, Brazil, 66.073-005
Los Alamitos, California, United States, 90720
Capital Federal, Argentina, C1017
Kaohsiung City, Taiwan, 833
Changzhou, China, 213004
Cheongju-si, South Korea, 28644
Duarte, California, United States, 91010
Long Beach, California, United States, 90813
Irvine, California, United States, 92618
Huntington Beach, California, United States, 92648
South Pasadena, California, United States, 91030
Westbury, New York, United States, 11590
Izmir, Turkey (Türkiye), 35100
Shanghai, China, 200032
São Paulo, Brazil, 01509 900
Jaú, Brazil, 17.210-080
São Paulo, Brazil, 01246 000
Incheon, South Korea, 21565
Ankara, Turkey (Türkiye), 06560
Ankara, Turkey (Türkiye), 06010
West Salem, Wisconsin, United States, 54669
Harbin, China, 150040
Zhengzhou, China, 450008
Hinsdale, Illinois, United States, 60521
Marseille, France, 13915
Nice, France, 06001
Málaga, Spain, 29010
A Coruña, Spain, 15006
Barcelona, Spain, 08035
Madrid, Spain, 28007
Alicante, Spain, 03010
Seville, Spain, 41014
Lugo, Spain, 27003
Barcelona, Spain, 08028
Jaén, Spain, 23007
Santa Cruz do Sul, Brazil, 96835-100
Buenos Aires, Argentina, C1199
La Plata, Argentina, B1900AXI
Porto Alegre, Brazil, 91350 200
Mar del Plata, Argentina, B7602
George Town, Malaysia, 10450
Kuantan, Malaysia, 25100
Kuching, Malaysia, 93586
Huizhou, China, 516001
Flemington, New Jersey, United States, 08822
Istanbul, Turkey (Türkiye), 34295
CABA, Argentina, C1122
Paris, France, 75005
Chandler, Arizona, United States, 85224
Vallejo, California, United States, 94589
Oakland, California, United States, 94611
Roseville, California, United States, 95661
San Francisco, California, United States, 94115
Santa Clara, California, United States, 95051
Walnut Creek, California, United States, 94596
Los Angeles, California, United States, 90033
Essen, Germany, 45136
Kassel, Germany, 34125
Curitiba, Brazil, 81520-060
Taoyuan City, Taiwan, 333
Glendale, California, United States, 91204
Taipei, Taiwan, 100
Hsinchu, Taiwan, 30059
Salvador, Brazil, 40170 070
Springfield, Missouri, United States, 65807
Samsun, Turkey (Türkiye), 55420
Fullerton, California, United States, 92835
Wilson, North Carolina, United States, 27893
Reno, Nevada, United States, 89502
Belo Horizonte, Brazil, 30150-221
Taubaté, Brazil, 12030-200
Seoul, South Korea, 03722
Chengdu, China, 610041
Taichung, Taiwan, 40705
Guangzhou, China, 510080
Hangzhou, China, 310003
Xi'an, China, 710061
Heidelberg, Germany, 69126
Newport Beach, California, United States, 92663
Giessen, Germany, 35392
Kiel, Germany, 24105
Aachen, Germany, 52074
Athens, Georgia, United States, 30607
Cleveland, Ohio, United States, 44106
Kuala Lumpur, Malaysia, 59100
Renton, Washington, United States, 98055
Fairfax, Virginia, United States, 22031
Chengdoucun, China, 610041
Nanjing, China, 210000
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials